Estrogens protect bone mass by inhibiting NAD+ metabolism in osteoclasts
Kim, H.-N.; Marques-Carvalho, A.; Adam, G. O.; Chalke, A.; Resende-Coelho, A.; Reyes-Castro, O.; Warren, A.; Grilo, L.; Chini, C. N.; Stronach, B.; Alturkmani, F.; Ambrogini, E.; Chini, E. N.; Almeida, M.
Show abstract
Estrogens protect against bone loss by reducing osteoclast number and bone resorption, primarily via direct actions on osteoclast precursors. In these cells, estrogens attenuate RANKL-induced stimulation of mitochondrial complex I, which is crucial for ATP generation through NADH oxidation. NAD+ promotes redox reactions and activates NAD+-dependent enzymes, including the mitochondrial deacetylase SIRT3. However, the contribution of NAD+ to the skeletal effects of estrogens remains unknown. We show that NAD+ levels and SIRT3 activity are upregulated by RANKL and inhibited by 17{beta}-estradiol (E2) in mouse and human osteoclast precursors. Increasing NAD+ or the mitochondrial NAD+/NADH ratio reverses the inhibitory effects of E2 on SIRT3 activity and osteoclastogenesis in vitro. Deletion of Nampt, a key NAD salvage enzyme, reduces NAD+ and prevents bone loss in ovariectomized mice. Similarly, deletion of Sirt3 in osteoclast precursors mitigates estrogen deficiency-induced bone resorption. These findings indicate that suppression of NAD+ levels and mitochondrial redox metabolism by estrogens contributes to their anti-resorptive effects via inhibition of SIRT3.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic mice 96%
- MicroRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling 96%
- O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors 96%
Similar papers in this journal
- SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters 97%
- Basigin Links Altered Skeletal Stem Cell Lineage Dynamics with Glucocorticoid-induced Bone Loss and Impaired Angiogenesis 96%
- A Genome-wide CRISPR Screen Identifies WDFY3 as a Novel Regulator of Macrophage Efferocytosis 96%
Similar papers in this journal
- The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts 95%
- Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis 94%
- Type I interferon potentiates metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice 94%
Similar papers in this journal
- Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation 97%
- Spatial Transcriptomics Reveals the Requirement of ADGRG6 in Maintaining Chondrocyte Homeostasis in Mouse Growth Plates 95%
- The circadian regulator PER1 inhibits osteoclastogenesis by activating inflammatory genes 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.